Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19282 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:17 UTC
19282
Studies in scope
all four open statuses
11840
Recruiting now
open to new participants
2032
Lead sponsors
across recruiting studies
Top sites
Beijing 5606 Shanghai 3892 Guangzhou 3359 Hangzhou 1833 Wuhan 1342
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University484 Fudan University480 Second Affiliated Hospital, Zhejiang University, School of Medicine402 Ruijin Hospital291 Peking Union Medical College Hospital280 AstraZeneca227 Beijing Tiantan Hospital221 Institute of Hematology & Blood Diseases Hospital, China215 Cancer Institute and Hospital, Chinese Academy of Medical Sciences212 The First Affiliated Hospital with Nanjing Medical University205 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University195 Shanghai Zhongshan Hospital178 Tianjin Medical University Cancer Institute and Hospital174 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology173 Peking University People's Hospital170 Xuanwu Hospital, Beijing167 West China Hospital166 Peking University Third Hospital163 Peking University First Hospital145 Chinese PLA General Hospital144 Tongji Hospital143 Nanfang Hospital, Southern Medical University142 RenJi Hospital135 Sichuan Baili Pharmaceutical Co., Ltd.131 Xijing Hospital128 Show all 2797
Site location
Beijing5606 Shanghai3892 Guangzhou3359 Hangzhou1833 Wuhan1342 Chengdu1310 Nanjing1216 Changsha1159 Chongqing1085 Fuzhou1041 Tianjin940 Zhengzhou926 Hefei909 Jinan794 Changchun642 Shenzhen585 Harbin549 Nanchang449 Nanning443 Xi'an443 Suzhou433 Shenyang406 Xiamen391 Shijiazhuang351 Lanzhou273 Show all 625
All 625 locations
Target enrolment
to

Trials in this register

19282 of 19282 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Phase 2
60
Guangzhou
2028-05-25
By invitation
Adaptive Neoadjuvant Therapy for Esophageal Cancer
NCT06990178Esophageal Carcinoma, Neoadjuvant Therapy
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Not applicable
43
Shenzhen
2028-03-01
Not yet open
Boehringer Ingelheim
Observational
5,000
Beijing
2028-01-31
Not yet open
Gritgen Therapeutics Co., Ltd.
Early Phase 1
9
Hefei
2027-12-31
Not yet open
Nanjing Medical University
Not applicable
300
Beijing, Changzhou, Chengdu, Fuzhou, Guangzhou, Nanchang, Nanjing, Shanghai
2027-12-31
Not yet open
RemeGen Co., Ltd.
Phase 1/2
26
Shanghai
2027-12-01
Not yet open
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
NCT07695740Relapsed or Refractory Multiple Myeloma (RRMM)
DrugYKST02
Excyte Biopharma Ltd
Phase 2
64
Beijing
2027-12
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Beijing, Chongqing, Guangzhou, Guiyang, Harbin, Wuhan, Changsha, Nanjing
2027-11-23
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
84
Hangzhou
2027-10-01
Not yet open
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
NCT07691645HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine, ICG (Indocyanine Green), Overall Survival (All-cause Mortality)
Xiang-Qian
Phase 2
120
Hangzhou
2027-09-01
Not yet open
Shanghai Mental Health Center
Observational
150
Shanghai
2027-09-01
Recruiting
Tianjin Medical University Second Hospital
Phase 2
15
Tianjin
2027-08-31
Not yet open
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
NCT07751003COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD, Hypercapnia
Sir Run Run Shaw Hospital
Not applicable
236
Zhengzhou, Changsha, Hangzhou, Wenling
2027-08-01
Not yet open
Anhui Provincial Hospital
Phase 2
59
Hefei
2027-08-01
Not yet open
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases
NCT07389499IgA Nephropathy (IgAN), Membranous Nephropathy, ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN), Refractory Podocytopathy
Grit Biotechnology
Early Phase 1
30
Shanghai
2027-08
Not yet open
Lentiviral Gene Therapy for CGD
NCT03645486Chronic Granulomatous Disease
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-07-01
Not yet open
Chinese University of Hong Kong
Not applicable
228
Chengdu
2027-07-01
Not yet open
Combination Immunotherapy Targeting Sarcomas
NCT04433221Sarcoma, Osteoid Sarcoma, Ewing Sarcoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-07-01
Not yet open
Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial
NCT04980703Sleep Initiation and Maintenance Disorders
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
102
Shanghai
2027-07-01
Not yet open
CAR-T Immunotherapy Targeting CD19- ALL
NCT04016129B-cell Leukemia
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-07-01
Not yet open
cfMSC Therapy for Diabetes
NCT07495956Type II Diabetes Mellitus
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Engineered Dendritic Cell Vaccines for Multiple Myeloma
NCT06435910Multiple Myeloma or Plasmacytoma
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2027-06-30
Not yet open
Universal CAR-T Cells Targeting Multiple Myeloma
NCT06006741Multiple Myeloma in Remission
Shenzhen Geno-Immune Medical Institute
Phase 1
20
Shenzhen
2027-06-30
Not yet open
Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)
NCT03645460Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-06-30
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
10
Shenzhen
2027-06-30
Not yet open
Universal CAR-T Cells Targeting AML
NCT05995041Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
Phase 1
30
Shenzhen
2027-06-30
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
NCT07501156Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
cfMSC Stem Cell Therapy Targeting COPD
NCT07477600Chronic Obstructive Pulmonary Disease (COPD)
DrugClonal fetal MSCs
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-30
Not yet open
Universal 4SCAR7U Targeting CD7-positive Malignancies
NCT05995028T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia, NK Cell Lymphoma
Shenzhen Geno-Immune Medical Institute
Phase 1
30
Shenzhen
2027-06-30
Not yet open
Lentiviral FVIII Gene Therapy
NCT03217032Hemophilia A
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2027-06-01
Not yet open
IT and IV Lentiviral Gene Therapy for X-ALD
NCT03727555X-linked Adrenoleukodystrophy
Shenzhen Geno-Immune Medical Institute
Not applicable
30
Shenzhen
2027-06-01
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-06-01
Not yet open
DLL3 CAR-T Therapy Targeting Brain Tumors
NCT07180927Glioblastoma of Cerebellum
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
Lentiviral FIX Gene Therapy
NCT03961243Hemophilia B
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2027-06-01
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-06-01
Not yet open
CAR-T Cells Targeting Autoimmune Diseases
NCT05459870Autoimmune Diseases
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
Multi-CAR-T Cells Targeting B Cell Lymphomas
NCT04429438B Cell Lymphoma (BCL)
Shenzhen Geno-Immune Medical Institute
Phase 1/2
11
Shenzhen
2027-06-01
Not yet open
Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD
NCT07046338Metachromatic Leukodystrophy (MLD)
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-06-01
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-06-01
Not yet open
CD19/22 Bi-specific CAR-T Cell Therapy
NCT05432882B Cell Malignancies
Shenzhen Geno-Immune Medical Institute
Phase 1/2
60
Shenzhen
2027-06-01
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2027-06-01
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2027-06-01
Not yet open
CD19/70 Bi-specific CAR-T Cell Therapy
NCT05436496B Cell Malignancies
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2027-06-01
Not yet open
Gansu University of Chinese Medicine
Not applicable
136
Lanzhou
2027-06
Not yet open
Shanghai HEP Pharmaceutical Co., Ltd.
Phase 3
150
Changchun
2027-06
Not yet open
Direct Lentiviral Injection Gene Therapy for MLD
NCT03725670Metachromatic Leukodystrophy (MLD)
Shenzhen Geno-Immune Medical Institute
Not applicable
10
Shenzhen
2027-05-31
Not yet open
Grit Biotechnology
Early Phase 1
36
Shenzhen
2027-05
Not yet open
Fujian Medical University Union Hospital
Observational
2,000
Fuzhou, Zhangzhou, Lanzhou, Mudanjiang, Liaocheng, Shanghai
2027-04-01
Not yet open
Fujian Medical University Union Hospital
Phase 3
1,266
Fuzhou
2027-04-01
Not yet open
Chen Xiangmei
Phase 4
410
Beijing, Chongqing, Dalian, Shanghai, Hangzhou
2027-03-01
Not yet open
Jiangsu Medical College
Not applicable
84
Yancheng
2027-03
Not yet open
Etern Therapeutics Wuxi Limited
Phase 2
90
Shanghai
2027-02-28
Not yet open
A Study of JMKX003142 Tablet to Treat Renal Edema
NCT07841093Renal Edema, Nephrogenic Edema
Jemincare
Phase 3
240
Shanghai
2027-02-28
Not yet open
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
NCT07470840Locally Advanced or Metastatic Renal Cell Carcinoma
DrugAnlotinib
Fujian Cancer Hospital
Phase 2
27
Fuzhou
2027-02-01
Not yet open
Liu Yang
Observational
300
Jinan
2027-02-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
80
Nanjing
2027-02-01
Recruiting
Zhujiang Hospital
Phase 1/2
15
Guangzhou
2027-02
Not yet open
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3
20
Hangzhou, Tianjin
2027-01-26
Not yet open
The First Affiliated Hospital of Zhengzhou University
Observational
100
Zhengzhou
2027-01-21
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Guiyang, Hangzhou, Hefei
2027-01-11
Not yet open
AstraZeneca
Phase 3
330
Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou
2027-01-04
Not yet open
LI FENG
Not applicable
224
Beijing
2027-01-01
Not yet open
Beijing Anzhen Hospital
Not applicable
6,000
Beijing
2027-01-01
Not yet open
ADC Based Therapy Accroding to HER2 Heterogeneous
NCT07844018Breast Cancer (Early Breast Cancer)
Peking University People's Hospital
Phase 2
88
Beijing
2027-01-01
Not yet open
West China Hospital
Observational
380
Chengdu
2027-01-01
Not yet open
Guangdong Provincial People's Hospital
Phase 3
148
Guangzhou
2027-01-01
Not yet open
AI for Newborn Metabolic Screening
NCT07368504Inherited Metabolic Disorders
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
200,000
Hangzhou
2027-01-01
Not yet open
Fujian Medical University Union Hospital
Observational
610
Fuzhou
2027-01-01
Not yet open
Peking University People's Hospital
Not applicable
160
Beijing
2027-01-01
Not yet open
Jinling Hospital, China
Early Phase 1
12
Nanjing
2027-01-01
Not yet open
TEER In dynaMic sEvere Functional Mitral Regurgitation (TIMER)
NCT07197021Mitral Regurgitation Functional
DrugGDMT
Sun Yat-sen University
Not applicable
540
Guangzhou
2027-01-01
Not yet open
Prince of Wales Hospital, Shatin, Hong Kong
Phase 3
130
Hong Kong
2027-01-01
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
190
Nanjing
2027-01-01
Not yet open
Ye Fan
Not applicable
116
Lhasa
2027-01-01
Not yet open
Blood Purification in Septic Children
NCT05595239Sepsis, Blood Purification
Children's Hospital of Fudan University
Not applicable
120
Shanghai
2027-01-01
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1
20
Guangzhou
2027-01-01
Not yet open
Cheng Zhou
Not applicable
190
Beijing
2027-01-01
Not yet open
Sacituzumab Tirumotecan Plus Toripalimab for Advanced Penile Cancer After Platinum Chemotherapy
NCT07907861Penile Squamous Cell Carcinoma (PSCC), Advanced Penile Cancer, Metastatic Penile Cancer, Locally Advanced Penile Cancer
DrugsSacituzumab tirumotecan·Toripalimab
Anhui Provincial Hospital
Phase 2
31
Hefei
2027-01-01
Not yet open
Chunshui He
Observational
600
Beijing, Xiamen, Hangzhou, Wuhan, Suzhou, Qingdao, Shanghai, Chengdu
2027-01-01
Not yet open
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Not applicable
120
Beijing
2027-01-01
Not yet open
Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer
NCT07890064Endometrioid Endometrial Cancer, Atypical Endometrial Hyperplasia
DrugsCanagliflozin·Metformin
Wang Yingmei
Phase 2
102
Tianjin
2027-01-01
Not yet open
Fudan University
Phase 2
46
Shanghai
2027-01-01
Not yet open
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
NCT07444463Schizophrenia, Bipolar Disorder, Major Depressive Disorder (MDD)
Central South University
Not applicable
400
Changsha
2027-01-01
Not yet open
Second Affiliated Hospital of Nanchang University
Not applicable
150
Nanchang
2027-01-01
Not yet open
Shanghai East Hospital
Not applicable
570
Shanghai
2027-01-01
Not yet open
Universiti Sains Malaysia
Not applicable
120
Yunfu
2027-01-01
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2027-01-01
Not yet open
Huanfang Fan
Not applicable
35
Shijiazhuang
2027-01-01
Not yet open
Beijing Hospital of Traditional Chinese Medicine
Not applicable
240
Beijing
2027-01
By invitation
Beijing Chao Yang Hospital
Observational
2,000
Beijing
2027-01
Not yet open
Beijing Tsinghua Chang Gung Hospital
Phase 4
190
Beijing
2027-01
Not yet open
Sun Yat-sen University
Phase 2
22
Guangzhou, Shenzhen
2027-01
Not yet open
Lepu Biopharma Co., Ltd.
Phase 3
231
Shanghai
2027-01
Not yet open
The Second Hospital of Anhui Medical University
Not applicable
440
Hefei, Huai'an, Yangzhou
2027-01
Not yet open
The Second Hospital of Anhui Medical University
Not applicable
440
Hefei
2027-01
Not yet open
Xi'an International Medical Center Hospital
Phase 4
462
Xi'an
2027-01
Not yet open
NK521 in the Treatment of Advanced Solid Tumors
NCT07657416Hepatocellular Carcinoma (HCC), Ovarian Cancer, Malignant Ascites
DrugNK521 Cell
Base Therapeutics (Shanghai) Co., Ltd.
Early Phase 1
18
Hefei
2027-01
Not yet open
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase 1
6
Hefei
2026-12-31
Not yet open
4SCAR19U T Cells Targeting B Cell Malignancies
NCT05995015B Cell Malignancies
Shenzhen Geno-Immune Medical Institute
Phase 1
30
Shenzhen
2026-12-31
Not yet open
The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study
NCT05560373Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage
Wanbangde Pharmaceutical Group Co., LTD
Phase 4
60
Hangzhou
2026-12-31
Not yet open
Immune Modulatory DC Vaccine Against Brain Tumor
NCT03914768Diffuse Intrinsic Pontine Glioma or Glioblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1
10
Shenzhen
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
10
Shenzhen
2026-12-31
Not yet open
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
NCT03222674Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute
Phase 1/2
10
Shenzhen
2026-12-31
Not yet open
GD2/CD70 Bi-specific CAR-T Cell Therapy
NCT05438368Cancer Disease
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2026-12-31
Not yet open
Donghua Zhang
Not applicable
28
Wuhan
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2026-12-31
Not yet open
Sunshine Lake Pharma Co., Ltd.
Phase 1
80
Jinan
2026-12-31
Not yet open
PSMA-specific CAR-T Cell Therapy
NCT04429451PSMA Positive Tumors or Tumor Tissues
Shenzhen Geno-Immune Medical Institute
Phase 1/2
100
Shenzhen
2026-12-31
Not yet open
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
NCT04033302T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia, NK Cell Lymphoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2
30
Shenzhen
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
60
Shenzhen
2026-12-31
Not yet open
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases
NCT07523282Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Sclerosis (SSc)
DrugHN2302
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase 1
12
Hefei
2026-12-31
Not yet open
PDS Versus NACT-IDS in AI-Selected Advanced Epithelial Ovarian Cancer
NCT07931313Epithelial Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer
Shanghai Gynecologic Oncology Group
Phase 2/3
534
Shanghai, Hangzhou
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Not applicable
20
Shenzhen
2026-12-31
Not yet open
θTACS for Schizophrenia (SCZ)
NCT07935746Schizophrenia Disorder
Anhui Medical University
Not applicable
150
Hefei
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1
100
Shenzhen
2026-12-31
Not yet open
Shenzhen Geno-Immune Medical Institute
Phase 1/2
20
Shenzhen
2026-12-31
Not yet open
RAPID for Unresectable Colorectal Liver Metastases
NCT07919951Colorectal Liver Metastases (CRCLM), Colorectal Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
10
Guangzhou
2026-12-30
Not yet open
Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery
NCT07574463Congenital Heart Disease (CHD), Congenital Heart Disease in Children
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
130
Hangzhou
2026-12-30
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
310
Nanjing
2026-12-30
Not yet open
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
NCT07349979Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease, Stable GDMT
DrugGDMT
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,154
Nanjing
2026-12-30
Not yet open
Fujian Medical University
Phase 3
118
Fuzhou
2026-12-25
Not yet open
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
76
Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen
2026-12-25
Not yet open
Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks
NCT07496762Stroke Sequelae, Deglutition Disorders, Acupuncture Therapy, Electroacupuncture
Kaili Chen
Not applicable
102
Hangzhou
2026-12-21
Not yet open
AstraZeneca
Phase 3
204
Beijing, Chifeng, Guangzhou, Hangzhou, Ha’erbin, Hefei, Liuzhou, Luoyang
2026-12-21
Not yet open
Minghui Pharmaceutical (Shanghai) LTD
Phase 1/2
400
Shanghai
2026-12-20
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
628
Hefei, Nanjing, Shanghai
2026-12-20
Not yet open
Xinqiao Hospital of Chongqing
Phase 2/3
1,192
Fuyang, Longyan, Xiangtan, Ganzhou, Jingdezhen, Jiujiang, Dalian, Mianyang
2026-12-19
Recruiting
Amgen
Phase 3
180
Hefei, Beijing, Chongqing, Fuzhou, Zhengzhou, Wuhan, Nanjing, Suzhou
2026-12-18
Recruiting
LI FENG
Not applicable
308
Beijing
2026-12-17
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Hefei, Beijing, Shenzhen, Guangzhou, Shenzhen Shi, Zhengzhou, Shijiazhuang, Yichang Shi
2026-12-16
Recruiting
Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care
NCT07372027Hemodialysis Access, Arteriovenous Fistula, Arteriovenous Fistula Cannulation, Vascular Access
Suzhou Municipal Hospital of Anhui Province
Not applicable
100
Suzhou
2026-12-15
Not yet open
A Phase I of FXS0260 in Advanced Solid Tumor
NCT07933666Solid Tumor Refractory to Conventional Treatment
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
20
Shanghai
2026-12-15
Recruiting
Sun Yat-sen University
Not applicable
10,000
Guangzhou
2026-12-15
Not yet open
Boehringer Ingelheim
Phase 3
270
Beijing, Chongqing, Dongguan, Guangzhou, Hefei, Luoyang, Nanchang, Nanjing
2026-12-14
Not yet open
Ruijin Hospital
Phase 4
20
Shanghai
2026-12-10
Not yet open
Suzhou Immunofoco Biotechnology Co., Ltd
Early Phase 1
30
Beijing
2026-12-10
Not yet open
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3
90
Tianjin
2026-12-10
Not yet open
A Study of TIL in Advanced Solid Tumors (CZ)
NCT07294872Solid Tumor, Adult
Shanghai Juncell Therapeutics
Phase 1
30
Chengdu
2026-12-08
Not yet open
Selumetinib for NF2-Related Schwannomatosis
NCT07707947Neurofibromatosis Type 2, NF2, NF2-related Schwannomatosis, Meningioma
DrugSelumetinib
Beijing Tiantan Hospital
Phase 2
20
Beijing
2026-12-01
Not yet open
Peking Union Medical College
Not applicable
400
Beijing
2026-12-01
Not yet open
Integrating Wearable Monitoring and Clinical Data for Stroke Early Warning
NCT07908303Stroke, Ischemic Stroke, Recurrent Stroke, Transient Ischemic Attack
Affiliated Hospital of Nantong University
Observational
5,000
Nantong
2026-12-01
Not yet open
Laryngotracheal Lesions in Adults With Long-Term Tracheostomy
NCT07901946Laryngotracheal Lesions, Tracheostomy Complications, Tracheal Stenosis, Tracheomalacia
Hongying Jiang, MD
Observational
220
Beijing
2026-12-01
Not yet open
Traditional Chinese Medicine in Multidrug-Resistant Bacterial Pneumonia
NCT07726095Multi Drug Resistant Infections, Pneumnia
Henan University of Traditional Chinese Medicine
Observational
652
Zhengzhou
2026-12-01
Not yet open
National Health Research Institutes, Taiwan
Phase 1
44
2026-12-01
Not yet open
Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)
NCT07920133Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Residual Inflammatory Risk
DrugColchicine
Sir Run Run Shaw Hospital
Not applicable
1,768
Hangzhou
2026-12-01
Not yet open
IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS
NCT07796412Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
China National Center for Cardiovascular Diseases
Not applicable
150
Beijing
2026-12-01
Not yet open
Single-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial)
NCT07934563Carotid Artery Stenosis, Carotid Artery Stenosis Asymptomatic, Atherosclerosis
Suzhou Zenith Vascular SciTech Limited
Not applicable
208
Beijing
2026-12-01
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
NCT07922044Critically Ill Patients Requiring Mechanical Ventilation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou, Shaoxing
2026-12-01
Not yet open
Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension
NCT07932145Hypertension (HTN), Low-Renin Essential Hypertension
DrugsTelmisartan·Eplerenone
China National Center for Cardiovascular Diseases
Phase 4
128
Beijing
2026-12-01
Not yet open
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
NCT07767526Schizophrenia, Antipsychotic Drug
Shanghai Mental Health Center
Phase 1/2
46
Shanghai
2026-12-01
Not yet open
AI-Assisted Precision Hyperbaric Oxygen Therapy Based on Dynamic BIS-EEG Feedback for Patients With Disorders of Consciousness
NCT07855848Disorders of Consciousness, Vegetative State, Minimally Conscious State
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.
Not applicable
200
Shenzhen
2026-12-01
Not yet open
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
NCT07718659Parkinson's Disease (PD), Parkinsonian Disorders
Qianfoshan Hospital
Phase 1
8
Jinan
2026-12-01
Recruiting
Hua Huang, MD, PhD
Phase 3
170
Beijing, Chongqing, Zhangzhou, Guangzhou, Wuhan, Nanjing, Nantong, Nanchang
2026-12-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
400
Hangzhou
2026-12-01
Not yet open
CSPC-NBP Pharmaceutical Co., Ltd.
Phase 2
300
Guangzhou
2026-12-01
Not yet open
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
300
Beijing
2026-12-01
Not yet open
Xiangya Hospital of Central South University
Observational
657
Changsha
2026-12-01
Not yet open
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Not applicable
152
Beijing, Kunming, Zhengzhou
2026-12-01
Not yet open
Multimodal Cohort Study of Generalized Anxiety Disorder
NCT07764211Generalized Anxiety Disorder (GAD)
Shanghai Mental Health Center
Observational
400
Shanghai
2026-12-01
Not yet open
Qilu Hospital of Shandong University
Not applicable
134
Jinan
2026-12-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
826
Hangzhou
2026-12-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
3,300
Hangzhou
2026-12-01
Not yet open
IMPT Versus IMRT for Diffuse Intrinsic Pontine Glioma
NCT07869524Diffuse Intrinsic Pontine Gliomas (DIPG)
Shandong Cancer Hospital and Institute
Phase 3
142
Jinan
2026-12-01
Not yet open
Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG
NCT07918781Postoperative Atrial Fibrillation, Coronary Artery Disease
China National Center for Cardiovascular Diseases
Not applicable
1,470
Beijing, Guangzhou, Zhenzhou, Changsha, Nanjing
2026-12-01
Not yet open
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
170
Guangzhou, Nanning, Nanchang, Taiyuan, Hangzhou
2026-12-01
Not yet open
SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors
NCT07903857Colorectal Neoplasms, Stomach Neoplasms, Solid Tumor Malignancies
Guizhou Sinorda Pharmaceutical Co., Ltd.
Phase 1
78
Guiyang, Hangzhou
2026-12-01
Not yet open
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
55
Tianjin
2026-12-01
Not yet open
West China Hospital
Not applicable
60
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanjing, Shanghai
2026-12-01
Not yet open
Beijing Tsinghua Chang Gung Hospital
Not applicable
140
Beijing
2026-12
Not yet open
Jiangsu Guiqiong Pharmaceutical Co., Ltd.
Phase 2
96
Beijing
2026-12
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 3
408
Wuhan
2026-12
Not yet open
Eli Lilly and Company
Phase 3
2,115
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Jinan
2026-12
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Not applicable
286
Wenzhou
2026-12
Not yet open
Daishi Tian
Early Phase 1
12
Wuhan
2026-12
Not yet open
Chinese PLA General Hospital
Not applicable
260
Beijing
2026-12
Not yet open
Eli Lilly and Company
Phase 3
3,000
Beijing, Chengdu, Guangzhou, Hangzhou, Harbin, Jinan, Liaoyou, Luoyang Shi
2026-12
Not yet open
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
NCT07189793Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Carcinoma in Situ of Bladder, Non-Muscle-Invasive Bladder Cancer
DrugsMitomycin C·JS001·Toripalimab·Gemcitabine
First Affiliated Hospital of Wenzhou Medical University
Phase 2
106
Wenzhou
2026-12
Not yet open
Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers
NCT07808502Diabetic Foot Ulcer, Damp-Heat Toxins Accumulation Syndrome
Chengdu University of Traditional Chinese Medicine
Not applicable
120
Chengdu
2026-12
Not yet open
Eli Lilly and Company
Phase 3
192
Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang Shi, Nanchang
2026-12
Recruiting
Women's Hospital School Of Medicine Zhejiang University
Observational
360
Hangzhou
2026-12
Not yet open
MYTP01 for Immune-Mediated Diseases
NCT07901764IgA Nephropathy, Kidney Transplant Recipients, Lupus Nephritis, Primary Membranous Nephropathy
Zhejiang Provincial People's Hospital
Not applicable
160
Hangzhou
2026-12
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
436
Shanghai, Hangzhou
2026-12
Not yet open
Clinical Trial of GenSci136 in Patients With Myasthenia Gravis
NCT07936084Patients With MG (gMG and oMG)
DrugGenSci136
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1/2
72
Shanghai
2026-12
Not yet open
Keymed Biosciences Co.Ltd
Phase 3
320
Tianjin
2026-12
Not yet open
HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid Malignancies
NCT07891377Chemotherapy-induced Anemia, Non-Myeloid Malignancy
Sunshine Lake Pharma Co., Ltd.
Phase 2
160
Shanghai
2026-12
Not yet open
The First Affiliated Hospital of University of Science and Technology of China
Phase 3
1,395
Hefei
2026-12
Not yet open
Longbio Pharma (Suzhou) Co., Ltd.
Phase 2
80
Hong Kong
2026-12
Not yet open
The Second Hospital of Anhui Medical University
Not applicable
136
Hefei
2026-12
Not yet open
Guangdong Second Provincial General Hospital
Not applicable
818
Hefei, Guangzhou
2026-12
Recruiting
Baduanjin Rehabilitation for Functional Restoration in ICI-Associated Myocarditis
NCT07280429Immune Checkpoint Inhibitors Related Myocarditis
China-Japan Friendship Hospital
Not applicable
60
Beijing
2026-12
Not yet open
BCMA/GPRC5D Dual-Target CAR-T Cell Immunotherapy for Relapsed/Refractory Multiple Myeloma
NCT07927842Multiple Myeloma; Relapsed/Refractory Multiple Myeloma
Liping Dou
Phase 1
20
Beijing
2026-11-30
Not yet open
Beijing Tsinghua Chang Gung Hospital
Not applicable
180
Beijing
2026-11-30
Not yet open
Xiangya Hospital of Central South University
Not applicable
15,400
Changsha
2026-11-30
Not yet open
Lee's Pharmaceutical Limited
Phase 1
36
Hefei
2026-11-30
Not yet open
Chinese University of Hong Kong
Observational
1,600
Hong Kong
2026-11-30
Not yet open
Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma
NCT07901569Carcinoma, Renal Cell, Inferior Vena Cava Tumor Thrombus
Liu Zhuo
Observational
273
Beijing
2026-11-30
Not yet open
CLL-1/CD70 Dual-Target CAR-T Cell Therapy for Acute Myeloid Leukemia
NCT07897136Acute Myeloid Leukemia (AML), Relapsed/Refractory Acute Myeloid Leukemia
Liping Dou
Phase 1
12
Beijing
2026-11-30
Not yet open
Zhai Wenlong
Phase 3
90
Zhengzhou
2026-11-30
Not yet open
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2
154
Tianjin
2026-11-30
Not yet open
AI-ECHO Hemodynamic Phenotyping in Septic Shock
NCT07924501Sepsis, Septic Shock, Septic Cardiomyopathy
Second Affiliated Hospital of Guangzhou Medical University
Observational
240
Guangzhou
2026-11-30
Not yet open
Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms
NCT07353749Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke, Methylprednisolone
DrugMethylprednisolone
Duan Chuanzhi
Phase 4
864
Guangzhou
2026-11-30
Not yet open
China National Center for Cardiovascular Diseases
Not applicable
400
Beijing
2026-11-30
Not yet open
Sinocelltech Ltd.
Phase 1
12
Tianjin
2026-11-30
Not yet open
BrightGene Bio-Medical Technology Co., Ltd.
Phase 2
160
Changsha
2026-11-30
Not yet open
Third Military Medical University
Not applicable
246
Nanjing, Panzhihua, Chongqing
2026-11-30
Not yet open
Sun Yat-sen University
Phase 2
91
Guangzhou
2026-11-30
Not yet open
Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections
NCT07892872Respiratory Viral Infections, Influenza, SARS CoV 2 Infection
Capital Medical University
Not applicable
618
Beijing
2026-11-30
Recruiting
Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients
NCT07709585Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 Mutation, EGFR Exon 21 L858R Mutation
DrugsCisplatin/Carboplatin·Pemetrexed
Guangzhou University of Traditional Chinese Medicine
Phase 2
124
Guangzhou
2026-11-30
Not yet open
Shanghai Henlius Biotech
Phase 2/3
1,438
Hefei, Beijing, Chongqing, Nanning, Zunyi, Shijiazhuang, Harbin, Anyang
2026-11-30
Not yet open
Bristol-Myers Squibb
Phase 2
80
Changsha Shi, Shanghai, Chengdu, Beijing
2026-11-30
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
490
Guangzhou
2026-11-30
Not yet open
The United Bio-Technology (Hengqin) Co., Ltd.
Phase 1
60
Changsha
2026-11-29
Not yet open
Health Information Framing, Source Characteristics, and Health Behavior Promotion
NCT07927387Vaccination, Mental Health, Health Behavior, Health Communication
Peking University
Not applicable
102,000
Beijing, Changsha
2026-11-28
Not yet open
Keymed Biosciences Co.Ltd
Phase 1/2
128
Shanghai
2026-11-27
Not yet open
Assessing the Time-Course of Dexmedetomidine-Induced Analgesia Via EEG
NCT06946277Total Hip Arthroplasty (THA), Intrathecal Anesthesia, Hip Osteoarthritis
China International Neuroscience Institution
Phase 4
20
Beijing
2026-11-25
Not yet open
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
500
Guangzhou
2026-11-25
Not yet open
Chunyan Zhu
Not applicable
150
Hefei
2026-11-25
Not yet open
Nanjing Immunophage Biotech Co., Ltd
Phase 1
72
Hangzhou
2026-11-25
Recruiting
The First Affiliated Hospital of Anhui Medical University
Early Phase 1
12
Hefei
2026-11-23
Not yet open
Breaks in Sedentary Behaviour and Executive Function
NCT07934030Sedentary Behavior / Physical Inactivity, Executive Function (Cognition)
Shenzhen University
Not applicable
30
Shenzhen
2026-11-23
Not yet open
Hunan Kelun Pharmaceutical Co., Ltd.
Phase 1
20
Changsha
2026-11-20
Not yet open
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
1,050
Tianjin
2026-11-20
Not yet open
Brise Pharmaceuticals Co., Ltd.
Phase 3
1,000
Shanxi, Inner Mongolia, Beijing, Anhui, Hebei, Jilin City, Hunan, Chongqing
2026-11-20
Not yet open
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
Phase 2
150
Beijing
2026-11-20
Not yet open
Renal Oxygenation-Guided AKI Reduction Trial
NCT07816640Acute Kidney Injury, Hepatectomy
Chinese PLA General Hospital
Not applicable
1,200
Hefei, Beijing, Chongqing, Lanzhou, Guangzhou, Nanning, Shijiazhuang, Harbin
2026-11-20
Not yet open
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
Phase 2
150
Beijing
2026-11-20
Not yet open
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 2
192
Beijing
2026-11-20
Not yet open
Xiamen Amoytop Biotech Co., Ltd.
Phase 1
40
Beijing, Wuhan, Xi'an, Xiamen
2026-11-20
Not yet open
Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy
NCT07263867Colonoscopy, Bowel Preparation, Quality of Healthcare
LanZhou University
Not applicable
300
Lanzhou
2026-11-20
Not yet open
Boehringer Ingelheim
Phase 3
600
Chengdu, Luoyang, Nanjing, Shanghai
2026-11-18
Not yet open
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase 1
80
Shanghai
2026-11-18
Not yet open
A Phase I Study of HLX109 in Healthy Participants
NCT07935941First in Man Study to Evaluate Initial Safety
Shanghai Henlius Biotech
Phase 1
64
Hefei
2026-11-18
Not yet open
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
13
Beijing
2026-11-18
Not yet open
The Second Affiliated Hospital of Chongqing Medical University
Observational
400
Chongqing, Hangzhou
2026-11-16
Not yet open
Nanjing Leads Biolabs Co.,Ltd
Phase 3
280
Bengbu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Nanning
2026-11-16
Not yet open
University of Macau
Not applicable
24
Hangzhou
2026-11-16
Not yet open
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
604
Guangzhou
2026-11-16
Not yet open
Model of Vaginal Laxity
NCT07933120Vaginal Laxity
Peking University People's Hospital
Observational
500
Beijing, Chengdu, Kunming, Lanzhou, Nanchang, Shenzhen
2026-11-15
Not yet open
Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Phase 1
88
Changsha, Xi'an, Shanghai, Huzhou
2026-11-15
Not yet open
Efficacy of Mazdutide on Fatty Pancreas
NCT07803705Fatty Pancreas, Overweight, Obesity
DrugMazdutide
Tongji Hospital
Not applicable
194
Wuhan
2026-11-15
Not yet open
Fudan University
Phase 3
394
Shanghai
2026-11-15
Not yet open
Different Exercise Modalities in Chronic Kidney Disease: A Longitudinal Intervention Study
NCT07932184Chronic Kidney Disease (CKD), Renal Dysfunction
China Institute of Sport Science
Not applicable
80
Beijing
2026-11-15
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
260
Foshan, Guangzhou, Jiangyin, Kunming, Liuzhou, Nanjing, Shanghai, Sichuan
2026-11-15
Not yet open
Beijing Ditan Hospital
Phase 3
778
Beijing
2026-11-15
Not yet open
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
120
Beijing
2026-11-15
Recruiting
Third Military Medical University
Not applicable
50
Chongqing
2026-11-15
By invitation
RenJi Hospital
Observational
40
Shanghai
2026-11-15
Not yet open
Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer
NCT07909863Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage
Tianjin Medical University Cancer Institute and Hospital
Phase 2
25
Tianjin
2026-11-15
Not yet open
Phase Ib/II Clinical Study of QLS5133 Combination Therapy in Advanced Solid Tumors
NCT07933419Clear Cell Renal Cell Carcinoma, Ovarian Cancer, Other Advanced Solid Tumors
DrugsQLS5133·Olaparib·Lenvatinib·Bevacizumab
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
558
Jinan
2026-11-15
Not yet open
Beijing Normal University
Not applicable
82
Beijing
2026-11-15
Not yet open
InnovStone Therapeutics Limited
Phase 2
60
Jinan
2026-11-13
Not yet open
Shanghai Chest Hospital
Not applicable
15
Shanghai
2026-11-13
Not yet open
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 2
80
Beijing
2026-11-13
Not yet open
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
24
Chongqing, Zhengzhou, Chengdu
2026-11-13
Recruiting
First Affiliated Hospital of Guangxi Medical University
Not applicable
68
Nanning
2026-11-12
Not yet open
Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation
NCT07637721Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Zhejiang University
Not applicable
410
Tianjin, Hangzhou
2026-11-12
Recruiting
The First Affiliated Hospital of Xiamen University
Phase 2
30
Xiamen
2026-11-11
Not yet open
Beijing HuiLongGuan Hospital
Not applicable
70
Hefei
2026-11-10
Not yet open
The Hong Kong Polytechnic University
Not applicable
60
Hong Kong
2026-11-10
Not yet open
Affiliated Hospital of Nantong University
Observational
80
Nantong
2026-11-10
Not yet open
AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRP
NCT07933757Coronary Heart Disease, Inflammation
DrugsArtesunate·Eplerenone·Leflunomide·Colchicine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
250
Wuhan
2026-11-10
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
34
Shanghai
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
1,060
Beijing, Chongqing, Shantou, Hengshui, Langfang, Shijiazhuang, Kaifeng, Luoyang
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
200
Chongqing, Nanjing, Zhenjiang, Jinan, Tianjin
2026-11-10
Recruiting
Hoffmann-La Roche
Phase 2
474
Shanghai
2026-11-10
Not yet open
Affiliated Hospital of Nantong University
Observational
80
Nantong
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
450
Hefei, Chongqing, Huizhou, Shenzhen, Hengshui, Shijiazhuang, Kaifeng, Luoyang
2026-11-10
Recruiting
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase 1/2
500
Guangxi
2026-11-10
Not yet open
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 2
180
Luoyang
2026-11-10
Not yet open
Tongji Hospital
Phase 2
80
Wuhan
2026-11-10
Not yet open
Study of Food Effects of VV261 Tablets in Healthy Trial Participants
NCT07927218Severe Fever With Thrombocytopenia Syndrome
Vigonvita Life Sciences
Phase 1
15
Hefei
2026-11-09
Not yet open
zhaoxiaohui
Not applicable
62
Guangzhou
2026-11-09
Not yet open
Nanjing Zenshine Pharmaceuticals
Phase 3
858
Beijing
2026-11-07
Not yet open
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 2
240
Nanjing
2026-11-06
Recruiting
A Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal Carcinoma
NCT07925021Previously Systemic Treatment-Naive Recurrent or Metastatic Nasopharyngeal Carcinoma
DrugsSYS6010·Enlonstobart·Tislelizumab
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 3
424
Guangzhou
2026-11-06
Not yet open
Beijing Tiantan Hospital
Not applicable
360
Beijing
2026-11-06
Not yet open
A Prospective, Multicenter, Controlled Clinical Study of Collagen Fibrous Scaffold for the Treatment of Cesarean Scar Diverticulum
NCT07930689Cesarean Scar Diverticulum, Abnormal Vaginal Bleeding, Fertility Impairment
Women's Hospital School Of Medicine Zhejiang University
Not applicable
80
Hangzhou
2026-11-06
Not yet open
Gan & Lee Pharmaceuticals.
Phase 1
124
Beijing
2026-11-05
Not yet open
Pregnancy Anti-inflammatory Diet Intervention Study
NCT07890441Pregnancy, Dietary Inflammatory Index (DII)
Capital Medical University
Not applicable
120
Beijing
2026-11-05
Not yet open
Xinghua Liu
Not applicable
108
Beijing
2026-11-05
Recruiting
West China Hospital
Phase 2
128
Chengdu
2026-11-05
Recruiting
Epidural Hydroxyethyl Starch for Post-Dural Puncture Headache in Parturients
NCT07914790Parturients, Accidental Puncture of Dura During Anaesthesia, Epidural Filling, Hydroxyethyl Starch
Peking University First Hospital
Observational
410
Beijing, Yinchuan, Taiyuan
2026-11-04
Recruiting
Tianjin Eye Hospital
Not applicable
200
Tianjin
2026-11-04
Not yet open
Sun Yat-sen University
Phase 2
29
Guangzhou
2026-11-04
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 3
476
Shanghai
2026-11-04
Not yet open
KRAS G12D-specific Immune Effector Cells Targeting KRAS G12D-positive Solid Tumors
NCT07924449Advanced Malignant Tumors With KRAS G12D Mutation
Shenzhen Geno-Immune Medical Institute
Not applicable
30
Shenzhen
2026-11-03
Recruiting
Huijie Zhang
Phase 4
820
Shanghai
2026-11-03
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
318
Hangzhou
2026-11-03
Active, closed
Triastek, lnc.
Phase 1
18
Suzhou
2026-11-03
Recruiting
Xidian University
Not applicable
60
Xi'an
2026-11-03
Recruiting
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
DrugsZL-1310·Obrixtamig·Atezolizumab
Boehringer Ingelheim
Phase 1/2
60
Nanning, Shanghai
2026-11-03
Not yet open
A Phase I Study to Evaluate the Food Effect on Ecnoglutide Tablet
NCT07936058Food Effect in Healthy Volunteers, Weight Management
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 1
72
Hangzhou
2026-11-03
Not yet open
Henan University of Traditional Chinese Medicine
Not applicable
320
Zhengzhou
2026-11-02
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 3
564
Zhengzhou
2026-11-02
Not yet open
Endovascular Brain-Computer Interface for Upper-Limb Paralysis
NCT07934914Stroke, Hemiplegia, Spinal Cord Injury, Paraplegia and Tetraplegia
Wei Wu
Not applicable
2
Nanjing
2026-11-02
Not yet open
Diansan Su
Not applicable
430
Sanjiaocheng, Xining, Hangzhou
2026-11-02
Recruiting
Genentech, Inc.
Phase 1
46
Beijing, Pingxiang
2026-11-02
Not yet open
Trastuzumab Rezetecan Followed by Pyrotinib, Fulvestrant, and Dalpiciclib in HR-Positive, HER2-Positive Advanced Breast Cancer
NCT07892274Metastatic Breast Cancer (MBC), HER2-Positive Breast Cancer, Hormone Receptor-Positive Breast Cancer
DrugsDalpiciclib·Pyrotinib·Trastuzumab Rezetecan·Fulvestrant
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
226
Guangzhou
2026-11-01
Not yet open
Beijing Municipal Administration of Hospitals
Observational
1,000
Beijing
2026-11-01
Not yet open
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
270
Fuzhou, Harbin, Changsha, Nanchang, Changchun, Shanghai, Taizhou
2026-11-01
Recruiting
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
NCT07795554Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University
Not applicable
60
Changsha
2026-11-01
Not yet open
Multi-omics Study of Cervical Neuroendocrine Carcinoma
NCT07879339Cervical Neuroendocrine Carcinoma
Peking Union Medical College Hospital
Observational
120
Beijing
2026-11-01
Not yet open
Children's Hospital of Fudan University
Phase 2/3
90
Nanchang, Shanghai
2026-11-01
Not yet open
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
NCT07884903Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)
Shanxi Bethune Hospital
Observational
25,974
Taiyuan
2026-11-01
Not yet open
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-11-01
Not yet open
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
NCT07720921Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant Therapy
Peking University First Hospital
Phase 2
20
Beijing
2026-11-01
Not yet open
Henan Cancer Hospital
Phase 2
155
Zhengzhou
2026-11-01
Not yet open
Capital University of Physical Education and Sports, China
Not applicable
38
Beijing
2026-11-01
Not yet open
Qilu Hospital of Shandong University
Observational
420
Jinan
2026-11-01
Not yet open
Modified Inhaled Nitric Oxide in Ventilated Patients With Acute Respiratory Failure
NCT07892001Acute Respiratory Failure (ARF), Nitric Oxide, Pneumonia
Southeast University, China
Not applicable
424
Nanjing
2026-11-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
200
Hangzhou, Yiwu
2026-11-01
By invitation
Zhejiang Provincial People's Hospital
Observational
350
Hangzhou
2026-11-01
Not yet open
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures
NCT07569575Tibial Fracture, Femoral Fracture, Humeral Fracture
HuaMg Perfection Med Tech (Suzhou) Co., Ltd.
Not applicable
160
Xicheng, Luoyang, Shijiazhuang, Xi'an, Xuhui
2026-11-01
Recruiting
CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors
NCT07423728Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
DrugG-Csf
First Affiliated Hospital of Zhejiang University
Not applicable
160
Zhengzhou, Wuhan, Hangzhou
2026-11-01
Not yet open
Xuanwu Hospital, Beijing
Not applicable
110
Beijing, Yangcheng
2026-11-01
Not yet open
Vincentage Pharma Co., Ltd
Phase 2
120
Beijing
2026-11-01
Not yet open
Intelligent Classification of Intraoperative Hemodynamic Phenotypes Based on CADFlow Doppler Monitoring
NCT06957587Ultrasound, Machine Learning, Intraoperative Hypotension, Hemodynamic Monitoring
Shanghai 6th People's Hospital
Observational
440
Shanghai
2026-11-01
Not yet open
Sir Run Run Shaw Hospital
Not applicable
106
Hangzhou
2026-11-01
Not yet open
Social Software-Based Intelligent Management System for Bowel Preparation
NCT07901257Colorectal Polyp, Colorectal Adenoma, Bowel Preparation, Artificial Intelligence
Shandong University
Not applicable
740
Jinan
2026-11-01
Not yet open
MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC )
NCT07904884ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia
First Affiliated Hospital of Zhejiang University
Not applicable
310
Zhejiang
2026-11-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
67
Nanjing
2026-11-01
Not yet open
First Hospital of China Medical University
Observational
2,400
Hefei, Chongqing, Fuzhou, Zhangzhou, Lanzhou, Tianshui, Guangzhou, Shantou
2026-11-01
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
41
Nanjing
2026-11-01
Not yet open
China National Center for Cardiovascular Diseases
Phase 3
270
Beijing, Guangzhou, Shenzhen, Zhangjiakou, Xinxiang, Zhengzhou, Wuhan, Baotou
2026-11-01
Not yet open
Neoadjuvant SHR-A1811 ± Adebrelimab in GC/GEJ
NCT07912957Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsTrastuzumab Rezetecan·Adebrelimab
Fudan University
Phase 2
62
Shanghai
2026-11-01
Not yet open
Peking University Third Hospital
Not applicable
260
Guangzhou, Beijing, Ningxia, Shanghai
2026-11-01
Not yet open
Positive- vs Negative-Pressure Extubation in High-Risk Patients
NCT07829627Positive Pressure Extubation Techniques, Negative Pressure Extubation Techniques, High-risk Patients Prone to Extubation Failure
Shanghai Zhongshan Hospital
Not applicable
96
Shanghai
2026-11-01
Not yet open
Zhongshan People's Hospital, Guangdong, China
Observational
1,500
Zhongshan, Nanning
2026-11-01
Not yet open
Hansoh BioMedical R&D Company
Phase 3
460
Hefei, Beijing, Chongqing, Xiamen, Guangzhou, Shaoguan, Nanning, Harbin
2026-11-01
Not yet open
Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma
NCT07828327Allergic Bronchopulmonary Aspergillosis, ABPA, Severe Eosinophilic Asthma
DrugDepemokimab
Qianfoshan Hospital
Not applicable
10
Jinan
2026-11-01
Not yet open
Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated Coagulopathy
NCT07897006Sepsis, Disseminated Intravascular Coagulation (DIC)
Shanghai Jiao Tong University School of Medicine
Not applicable
210
Shanghai
2026-11-01
Not yet open
Development and Prospective Validation of the AutoEIT Foundation Model for ARDS
NCT07898319ARDS (Acute Respiratory Distress Syndrome), Respiratory Failure, Mechanical Ventilation, Ventilator-induced Lung Injury (VILI)
Ruijin Hospital
Observational
1,200
Shanghai
2026-11-01
Not yet open
Peking University People's Hospital
Phase 2
100
Beijing
2026-11-01
Not yet open
Immunotherapy in Neuroendocrine Carcinoma of the Cervix
NCT07911423Cervical Neuroendocrine Carcinoma
Peking Union Medical College Hospital
Observational
150
Beijing
2026-11-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
27
Beijing
2026-11-01
Not yet open
Tao Zhang
Phase 2
144
Wuhan
2026-11-01
Not yet open
D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer
NCT07912606Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
32
Nanjing
2026-11-01
Not yet open
AI-Assisted Differentiation of Pancreatic Cystic Lesions Using EUS Images and Clinical Features
NCT07919704Pancreatic Mucinous Cystic Neoplasm, Pancreatic Serous Cystic Neoplasm, Pancreatic Pseudocyst
Ruijin Hospital
Observational
400
Shanghai
2026-11-01
Not yet open
NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC
NCT07919717Hepatocellular Carcinoma (HCC), Recurrent Hepatocellular Cancer
DrugsYervoy·Ipilimumab·Opdivo·Nivolumab
Shanghai Zhongshan Hospital
Phase 2
35
Shanghai
2026-11-01
Not yet open
Sun Yat-sen University
Phase 2
229
Guangzhou, Shanghai
2026-11-01
Not yet open
Shiyou Wei
Not applicable
120
Shaoyang
2026-11-01
Not yet open
Anhui Medical University
Not applicable
100
Hefei
2026-11-01
Recruiting
China Aortic Infection and Graft Infection Study: An Ambispective Cohort
NCT07847346Vascular Graft Infection, Infectious Aortitis, Aortoenteric Fistula
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2026-11-01
Not yet open
Second Affiliated Hospital of Nanchang University
Phase 1/2
55
Nanchang
2026-11-01
Not yet open
The First Affiliated Hospital of Shihezi University
Not applicable
200
Shihezi, Chongqing, Yining
2026-11-01
Not yet open
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
87
Beijing
2026-11-01
Not yet open
Beijing Tiantan Hospital
Observational
105
Beijing
2026-11-01
Not yet open
Oculomotor-Pupillary AI Biomarkers in Parkinson's
NCT07886450PARKINSON DISEASE (Disorder)
The Hong Kong Polytechnic University
Observational
128
Zhengzhou
2026-11-01
Not yet open
Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery
NCT07854145Congenital Heart Disease (CHD), Postoperative Sleep
Shanghai Jiao Tong University School of Medicine
Not applicable
172
Shanghai
2026-11-01
Not yet open
Shanghai Jiao Tong University School of Medicine
Not applicable
280
Shanghai
2026-11-01
Not yet open
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
NCT07781150Obesity, Overweight, Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I
DrugMazdutide
Tongji Hospital
Phase 2
128
Zhengzhou, Wuhan, Changchun, Hangzhou, Shanghai, Tianjin
2026-11-01
Recruiting
Listening Volume Adjustment in Bone and Air Conduction Headphones
NCT07932964Noise Exposure, Preferred Loudness Level, Normal Hearing
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
32
Hangzhou
2026-11-01
Not yet open
Impact of Closed PBSC Collection With Reduced Gas-Phase Oxygen Exposure on Graft Quality and Early Engraftment in Allo-HSCT
NCT07904234Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Oxygen Deficiency, Graft Function
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
240
Tianjin
2026-11-01
Not yet open
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
NCT07725484Heart Failure Due to Coronary Artery Disease
DrugAlpha Lipoic Acid
Shanghai Zhongshan Hospital
Phase 3
1,188
Hefei, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Nanjing, Dalian, Xi'an
2026-11-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 1
80
Nanjing
2026-11-01
Not yet open
Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
NCT07919470Acute Lymphoblastic Leukemia, Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Not applicable
180
Beijing
2026-11-01
Not yet open
Guangdong Provincial Hospital of Traditional Chinese Medicine
Not applicable
50
Zhuhai
2026-11-01
Not yet open
Peking University People's Hospital
Not applicable
50
Beijing
2026-11-01
Not yet open
Beijing Tiantan Hospital
Not applicable
100
Beijing
2026-11-01
Not yet open
Shiwei Anshen Granules for Chronic Insomnia
NCT07895329Chronic Insomnia
Dongzhimen Hospital, Beijing
Not applicable
240
Beijing
2026-11-01
Not yet open
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2
87
Luoyang
2026-11-01
Not yet open
Multi-center Prospective Validation of Real-Time AI-EGGIM System
NCT07915843Gastric Intestinal Metaplasia
Qilu Hospital of Shandong University
Observational
540
Binzhou, Jinan, Qingdao
2026-11-01
Recruiting
Ruijin Hospital
Phase 1/2
78
Shanghai, Chengdu
2026-11-01
Not yet open
Sir Run Run Shaw Hospital
Not applicable
120
Hangzhou
2026-11-01
Not yet open
Bing Han
Not applicable
30
Beijing
2026-11-01
Not yet open
Magnesium Alloy Scaffold With Controlled Degradation for Periarticular Bone Defects
NCT07906730Periarticular Bone Defect, Proximal Humerus Fracture, Distal Radius Fracture, Tibial Plateau Fracture
Peking University Third Hospital
Not applicable
120
Beijing
2026-11-01
Not yet open
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
348
Shanghai
2026-11
Not yet open
China Institute of Sport Science
Not applicable
212
Jining
2026-11
Not yet open
GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT07891364Autosomal Dominant Polycystic Kidney
RenJi Hospital
Early Phase 1
24
Shanghai
2026-11
Recruiting
Fudan University
Phase 2
220
Shanghai
2026-11
Not yet open
Shanghai Teyi Yinuo Health Technology Co., Ltd.
Not applicable
50
Shanghai
2026-11
Not yet open
The Preventive Efficacy of ULP for Stress Urinary Incontinence After Pelvic Organ Prolapse Surgery
NCT07923968Stress Urinary Incontinence in Women, Pelvic Organ Prolapse (POP)
Peking University People's Hospital
Not applicable
236
Beijing, Guangzhou, Nanchang, Shanghai, Hangzhou
2026-11
Not yet open
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
40
Guangzhou, Xi’an
2026-11
Not yet open
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
450
Nanjing, Shanghai
2026-11
Not yet open
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Phase 1/2
90
Hefei
2026-11
Not yet open
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
NCT07912801Coronary Artery Disease, Coronary Artery Bypass Grafting, Hypoxia-Inducible Factor 1, Alpha Subunit, Prolyl-Hydroxylase Inhibitors
DrugRoxadustat
Peking University First Hospital
Phase 4
80
Beijing
2026-11
Not yet open
Phase I Study of JY1001 Injection
NCT07848945Pain After Surgery
Jemincare
Phase 1
48
Chengdu
2026-11
Not yet open
Shanghai 7th People's Hospital
Not applicable
216
Shanghai
2026-11
Not yet open
China National Center for Cardiovascular Diseases
Not applicable
294
Beijing
2026-11
Recruiting
First People's Hospital of Hangzhou
Observational
1,000
Fuzhou, Guangzhou, Jinan, Hangzhou, Beijing, Shanghai, Tianjin
2026-11
Not yet open
A Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis
NCT07909655Idiopathic Pulmonary Fibrosis (IPF)
DrugHB0056
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 2
75
Changsha, Shanghai
2026-11
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
37
Guangzhou
2026-11
Not yet open
RemeGen Co., Ltd.
Phase 2/3
680
Beijing, Shanghai
2026-11
Not yet open
Peking University First Hospital
Phase 4
658
Beijing
2026-11
Not yet open
A Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBS
NCT07896187PARKINSON DISEASE (Disorder), Cell Therapy, Human Induced Pluripotent Stem Cells, Deep Brain Stimulation
Nuwacell Biotechnologies Co., Ltd.
Phase 1
12
Beijing
2026-11
Not yet open
EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia
NCT07894315Ischemic Stroke, Post-stroke Dysphagia, Swallowing Disorders
First Affiliated Hospital of Fujian Medical University
Not applicable
60
Fuzhou, Zhangzhou, Zhengzhou, Xi'an, Beijing
2026-11
Not yet open
A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older
NCT07908654Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine
Guangzhou Patronus Biotech Co., Ltd.
Phase 3
25,000
Nanjing
2026-11
Not yet open
a2 Milk Company Ltd.
Not applicable
80
Shenzhen
2026-11
Recruiting
Sir Run Run Shaw Hospital
Observational
3,000
Hangzhou
2026-11
Not yet open
Vigonvita Life Sciences
Phase 2
200
Beijing
2026-11
Not yet open
Harbin Medical University
Not applicable
52
Daqing
2026-11
Recruiting
Shanghai Mental Health Center
Not applicable
160
Shanghai
2026-11
Not yet open
RemeGen Co., Ltd.
Phase 2
412
Guangdong
2026-11
Not yet open
Phase II Study to Evaluate Telisotuzumab Adizutecan in Combination With RC148(ABBV-1480) as First-Line Treatment for Patients With Non-Squamous Non-Small-Cell Lung Cancer
NCT07874282Patients With Locally Advanced or Metastatic Non-Squamous NSCLC Requiring First-Line Treatment and no Driver Gene Alterations Confirmed by Histology or Cytology
DrugsRC148·Telisotuzumab Adizutecan
RemeGen Co., Ltd.
Phase 2
200
Shanghai
2026-11
Not yet open
Mindfulness Intervention on Minimally Invasive Vascular Surgery
NCT07463638Anxiety, Pain, Varicose Veins of Lower Limb
Tongji Hospital
Not applicable
160
Wuhan
2026-11
Not yet open
Techpool Bio-Pharma Co., Ltd.
Phase 1
40
Hefei
2026-11
Not yet open
Junyu Shi
Observational
60
Shanghai
2026-11
Not yet open
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1
18
Changsha
2026-11
Not yet open
Fudan University
Observational
14
Shanghai
2026-11
Not yet open
Exploratory Study of the Efficacy of HAL-PDT in CIN 3
NCT07891338Cervical Intraepithelial Neoplasia Grade 3
Tongji Hospital
Phase 2
260
Wuhan
2026-11
Not yet open
Eddingpharm (Zhuhai) Co., Ltd.
Phase 2
144
Harbin, Zhejiang
2026-11
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
32
Hefei
2026-11
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 2
34
Zhengzhou
2026-11
Not yet open
Ruijin Hospital
Phase 1
10
Shanghai
2026-11
Not yet open
Shihezi University
Not applicable
800
Shihezi
2026-11
Not yet open
Xuanwu Hospital, Beijing
Not applicable
60
Beijing
2026-11
Not yet open
Liangyou Gu
Early Phase 1
6
Beijing
2026-11
Not yet open
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
680
Shenzhen, Shanghai
2026-11
Not yet open
Intranasal Dexmedetomidine-esketamine Combination and Postoperative Cognitive Recovery in Older Patients
NCT07914803Older Patients, Noncardiac Surgery, Dexmedetomidine, Esketamine
Peking University First Hospital
Phase 4
732
Beijing
2026-11
Not yet open
Peking Union Medical College Hospital
Phase 2/3
126
Beijing
2026-11
Recruiting
Clinical Study on CD20 Monoclonal Antibody for Preventing Early EB Virus Activation After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07929974EBV Activation and EBV-PTLD After Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Phase 2/3
214
Hefei, Zhengzhou, Huai'an, Nanjing, Xuzhou, Hangzhou, Beijing, Chongqing
2026-11
Not yet open
Central South University
Not applicable
80
Changsha
2026-11
Not yet open
Beijing Gene Key Life Technology Co., Ltd
Phase 1
12
Beijing
2026-11
Not yet open
Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With Advanced HCC Who Have Failed or Progressed on Standard Systemic Therapy Containing ICIs
NCT07861425Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Metastatic, Hepatocellular Carcinoma Non-Resectable
Acepodia Biotech, Inc.
Phase 1
70
Nanjing, Shanghai
2026-11
Not yet open
Galderma R&D
Not applicable
326
Chengdu
2026-11
Not yet open
Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System Lymphoma
NCT07888621PCNSL (Primary CNS Lymphoma), Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma (SCNSL)
DrugsGlofitamab·Obinutuzumab·Oxaliplatin·Gemcitabine
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2026-11
Not yet open
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
140
Nanjing, Beijing
2026-11
Not yet open
Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.
NCT07854977Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
40
Tianjin
2026-11
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
690
Nanjing, Shanghai
2026-11
Not yet open
Shandong Suncadia Medicine Co., Ltd.
Phase 1
18
Guangzhou
2026-11
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
60
Tianjin
2026-11
Not yet open
Firmonertinib Plus Chemotherapy for Unresectable EGFR PACC-Mutant Stage III Lung Cancer: A Phase II Study
NCT07878871Lung Adenocarcinoma, Stage III Lung Cancer, EGFR Positive Non-small Cell Lung Cancer
DrugFurmonertinib
Hunan Province Tumor Hospital
Phase 2
27
Changsha
2026-11
Not yet open
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 1
50
Hefei
2026-11
Not yet open
Intranasal Esketamine-dexmedetomidine Combination in Patients With Postherpetic Neuralgia
NCT07934901Postherpetic Neuralgia, Esketamine, Dexmedetomidine, Intranasal Administration
Peking University First Hospital
Phase 4
80
Beijing
2026-11
Not yet open
Dermavon Holdings Limited
Phase 3
174
Hefei, Beijing, Chongqing, Guangzhou, Jiangmen, Shenzhen, Nanning, Chengde
2026-11
Not yet open
A Phase 3 Study of Deutenzalutamide in Patients With High-Risk BCR Prostate Cancer
NCT07875881High Risk Biochemical Recurrence (BCR), Deutenzalutamide Soft Capsules
Hinova Pharmaceuticals Inc.
Phase 3
1,044
Beijing, Shanghai, Chengdu
2026-10-31
Not yet open
Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT07796256PNH - Paroxysmal Nocturnal Hemoglobinuria
DrugSGB-9768
Suzhou Sanegene Bio Inc.
Phase 2
24
Tianjin, Hangzhou
2026-10-31
Not yet open
A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents
NCT07836270Adolescents With Obesity, Adolescents With Overweight & Weight-related Comorbidities
DrugEcnoglutide
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3
192
Hangzhou
2026-10-31
Not yet open
Sun Yat-sen University
Phase 2
100
Guangzhou
2026-10-31
Not yet open
Xiamen Amoytop Biotech Co., Ltd.
Phase 1
24
Beijing, Shanghai, Xi'an, Xiamen
2026-10-31
Not yet open
China CRSwNP Registry Study
NCT07795658Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Beijing Tongren Hospital
Observational
1,000
Beijing
2026-10-31
Not yet open
Xuanwu Hospital, Beijing
Not applicable
38
Beijing
2026-10-31
Not yet open
Sichuan University
Phase 2
30
Chengdu
2026-10-31
By invitation
First Affiliated Hospital of Zhejiang University
Observational
10,000
Hangzhou, Lishui
2026-10-31
Not yet open
Hansoh BioMedical R&D Company
Phase 1
595
Guangzhou
2026-10-31
Recruiting
Beijing Chao Yang Hospital
Not applicable
90
Beijing
2026-10-31
Not yet open
Peking University First Hospital
Phase 2
33
Beijing
2026-10-31
Not yet open
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
124
Hangzhou
2026-10-31
Recruiting
Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Phase 1
20
Changsha, Suzhou
2026-10-31
Not yet open
Peking Union Medical College Hospital
Not applicable
142
Beijing
2026-10-31
Recruiting
SKCD in Early Relapsed/Refractory Multiple Myeloma
NCT07931391Multiple Myeloma (MM)
Beijing Chao Yang Hospital
Phase 2
66
Beijing
2026-10-31
Recruiting
Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories
NCT07767396Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)
Shaanxi Normal University
Not applicable
117
Xi'an
2026-10-30
Recruiting
Shandong Boan Biotechnology Co., Ltd
Phase 1
120
Beijing
2026-10-30
Not yet open
A Study of hBMMSC Injection in Patients With aPAP
NCT07890649Autoimmune Pulmonary Alveolar Proteinosis
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
Phase 2
70
Guangzhou
2026-10-30
Not yet open
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 2
120
Beijing
2026-10-30
Not yet open
ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC
NCT07897188EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), MET Positive
DrugsASKC202·Limertinib·Osimertinib·Pemetrexed
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase 3
425
Shanghai
2026-10-30
Not yet open
Fudan University
Phase 2
19
Shanghai
2026-10-30
Recruiting
GST101 in Participants With RAS-Mutant Advanced Solid Tumors
NCT07868172RAS-mutant Advanced Solid Tumors
Genuine Seed Therapeutics (Zhuhai) Co., Ltd.
Phase 1/2
172
Harbin, Wuhan, Jinan, Shanghai, Chengdu, Hangzhou
2026-10-30
Not yet open
Xiamen Amoytop Biotech Co., Ltd.
Phase 1
24
Beijing, Shanghai, Ürümqi, Xiamen
2026-10-30
Not yet open
Guizhou Medical University
Phase 2
40
Guiyang
2026-10-30
Not yet open
Yunnan Cancer Hospital
Phase 1/2
30
Kunming
2026-10-30
Not yet open
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2/3
480
Shanghai
2026-10-30
Not yet open
China Healthy Aging and Fitness Longitudinal Study
NCT07881094Physical Fitness, Aging
China Institute of Sport Science
Observational
8,960
Beijing
2026-10-30
Not yet open
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
364
Beijing
2026-10-30
Not yet open
IIIb Trial for RC28-E Injection in Participants With DME and wAMD
NCT07936487Diabetic Macular Edema (DME), wAMD
RemeGen Co., Ltd.
Phase 3
350
Beijing
2026-10-30
Not yet open
Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection
NCT07672496Complicated Intra-abdominal Infection (cIAI), Systemic Inflammatory Response, Sepsis, Immune Dysfunction
DrugUlinastatin
Fujian Medical University Union Hospital
Not applicable
165
Fuzhou
2026-10-30
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
660
Guangzhou
2026-10-30
Not yet open
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1
40
Hefei
2026-10-30
Not yet open
Dai, Guanghai
Phase 2
46
Beijing
2026-10-29
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
132
Jing’an
2026-10-29
Not yet open
The Third Affiliated hospital of Zhejiang Chinese Medical University
Not applicable
60
Hangzhou
2026-10-29
Not yet open
Foraminal Imaging and Symptoms in Single-Level Degenerative Lumbar Stenosis
NCT07917962Degenerative Lumbar Spinal Stenosis, Lumbar Foraminal Stenosis
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Observational
120
Guangzhou
2026-10-29
Not yet open
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 3
70
Beijing, Jilin City, Quanzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan
2026-10-29
Not yet open
Ausper Biopharma Co., Ltd.
Phase 1
110
Shanghai
2026-10-28
Not yet open
The Hong Kong Polytechnic University
Not applicable
30
Shenzhen
2026-10-28
Not yet open
Ruijin Hospital
Not applicable
56
Qingdao, Shanghai, Xi’an, Chengdu
2026-10-28
Not yet open
Daishi Tian
Early Phase 1
12
Wuhan
2026-10-28
Not yet open
Peking University Third Hospital
Not applicable
144
Beijing
2026-10-28
Not yet open
Capital Medical University
Phase 3
600
Beijing
2026-10-28
Recruiting
Pfizer
Phase 3
432
Hefei, Beijing, Huizhou, Zhengzhou, Nanjing, Nanchang
2026-10-28
Recruiting
Peking University Third Hospital
Not applicable
60
Beijing
2026-10-28
Recruiting
Fifth Affiliated Hospital, Sun Yat-Sen University
Observational
364
Zhuhai
2026-10-28
Recruiting
The First Hospital of Jilin University
Phase 3
148
Changchun
2026-10-28
Recruiting
Merz North America, Inc.
Not applicable
163
Beijing, Changde, Chengdu, Gaozhou, Hangzhou, Nanjing, Xianyang, Yibin
2026-10-27
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
12
Tianjin
2026-10-27
Recruiting
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-10-27
Recruiting
A Phase I Clinical Study of YN003 in the Treatment of Glioma
NCT07929909Glioma, Glioblastoma, Brain Neoplasms
Beijing Inno Medicine Co., Ltd.
Phase 1
50
Beijing
2026-10-27
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
556
Shanghai
2026-10-27
Recruiting
The Intervention Effect of Exercise on Lumbar Multifidus Muscle Injuries
NCT07892846Chronic Non-specific Low Back Pain, Lumbar Multifidus Muscle Injury
Chinese PLA General Hospital
Not applicable
40
Beijing
2026-10-26
Recruiting
Fudan University
Observational
3,000
Shanghai
2026-10-26
Recruiting
Mabsoft Therapeutics (Shanghai) Co., Ltd.
Phase 1
420
Shanghai
2026-10-26
Recruiting
tACS for Working Memory in Schizophrenia
NCT07701343Schizophrenia, Working Memory
Central South University
Not applicable
30
Changsha
2026-10-26
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Beijing, Chongqing, Guangzhou, Shijiazhuang, Luoyang, Changsha, Changzhou, Nanjing
2026-10-26
Not yet open
Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
NCT07609654Intracerebral Hemorrhage, Atrial Fibrillation (AF), Ischemia Stroke
DrugApixaban
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
852
Hangzhou
2026-10-26
Not yet open
Tongji University
Observational
200
Shanghai
2026-10-25
Not yet open
Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients
NCT07897305Atrial Fibrillation (AF), Ablation Treatment, Obesity & Overweight, Mazdutide
DrugMazdutide
Beijing Anzhen Hospital
Not applicable
700
Beijing
2026-10-25
Not yet open
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
6
Wuxi
2026-10-25
Not yet open
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Not applicable
150
Shenzhen
2026-10-25
Recruiting
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
15
Tianjin
2026-10-25
Recruiting
U69-CART-Cells For R/R T-ALL
NCT07350863Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University
Phase 1
12
Suzhou
2026-10-25
Not yet open
Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma
NCT07902596Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Observational
2,000
Shijiazhuang, Lianyungang, Nanjing, Suzhou, Qingdao, Shanghai
2026-10-25
Recruiting
Anatomic Versus Nonanatomic Liver Resection After Conversion Therapy for Hepatocellular Carcinoma
NCT07927452Hepato Cellular Carcinoma (HCC), Liver Resection, Conversion Therapy
Sun Yat-sen University
Observational
874
Guangzhou
2026-10-25
Not yet open
The First Affiliated Hospital of Guangzhou Medical University
Phase 4
100
Guangzhou
2026-10-25
Recruiting
China National Center for Cardiovascular Diseases
Not applicable
182
Beijing
2026-10-25
Not yet open
Central South University
Not applicable
75
Fuzhou, Changsha, Yangzhou
2026-10-25
By invitation
Pain Assessment After Pediatric Indirect Inguinal Hernia Surgery
NCT07936981Postoperative Status, Inguinal Hernia in Children
Xiangya Hospital of Central South University
Not applicable
100
Changsha
2026-10-23
Not yet open
Pfizer
Phase 1
80
Shenzhen
2026-10-23
Rows per page Showing 1–500 of 19282
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-china

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,282 studies in total at the last sync on 15 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,840 of the 19,282 studies in this register are recruiting new participants as of the 15 Nov 2026, 03:17 UTC sync. A further 4,027 have not yet opened recruitment, 2,727 are active but closed to new participants, and 688 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 19,282 studies
PhaseStudiesRecruitingShare
Not applicable4,7152,73824.5%
Observational4,0332,61620.9%
Phase 23,6712,27519%
Phase 32,2691,25111.8%
Phase 11,7451,1369%
Phase 1/21,2878806.7%
Phase 46863803.6%
Early Phase 15673632.9%
Phase 2/33092011.6%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Sun Yat-sen University484297
Fudan University480313
Second Affiliated Hospital, Zhejiang University, School of Medicine402278
Ruijin Hospital291181
Peking Union Medical College Hospital280182
AstraZeneca227120
Beijing Tiantan Hospital221152
Institute of Hematology & Blood Diseases Hospital, China215150
Cancer Institute and Hospital, Chinese Academy of Medical Sciences212139
The First Affiliated Hospital with Nanjing Medical University205133

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (424) Advanced Solid Tumors (188) Colorectal Cancer (183) Gastric Cancer (176) Hepatocellular Carcinoma (154) Advanced Solid Tumor (153) Non-Small Cell Lung Cancer (145) Solid Tumor (142) Acute Ischemic Stroke (142) Lung Cancer (136) Non-small Cell Lung Cancer (133) Pancreatic Cancer (132) Multiple Myeloma (128) Coronary Artery Disease (122) Prostate Cancer (113)
→

Browse trials by site location

Beijing (5606) Shanghai (3892) Guangzhou (3359) Hangzhou (1833) Wuhan (1342) Chengdu (1310) Nanjing (1216) Changsha (1159) Chongqing (1085) Fuzhou (1041) Tianjin (940) Zhengzhou (926) Hefei (909) Jinan (794) Changchun (642)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.